Senate Committee Turns 340B Spotlight on DrugmakersLawmakers turned their sharp scrutiny of the 340B program on drugmakers Tuesday, questioning why states and providers don’t know the ceiling prices
Federal Watchdogs Urge More Oversight of Drug Discount ProgramOfficials from two federal watchdogs told a Senate committee Tuesday that a drug discount program for hospitals needs additional transparency and oversight